Autonomix Medical, Inc. (AMIX)
(Delayed Data from NSDQ)
$1.31 USD
-0.03 (-2.24%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.31 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
AMIX 1.31 -0.03(-2.24%)
Will AMIX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMIX
Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why
AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech
AMIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results
Other News for AMIX
USPTO Issuance Sends Micro Cap Soaring
12 Health Care Stocks Moving In Tuesday's Intraday Session
Autonomix (AMIX) Medical Announces Warrant Exercise Agreements | AMIX Stock News
Autonomix Medical Announces exercise of warrants for $2.5M gross proceeds